Patent application number | Description | Published |
20140018546 | Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) - Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease. | 01-16-2014 |
20150045563 | Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) - Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease. | 02-12-2015 |
20160046575 | Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) - Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease. | 02-18-2016 |
Patent application number | Description | Published |
20110106019 | DEVICES FOR CLEARING BLOCKAGES IN IN-SITU ARTIFICIAL LUMENS - Devices and methods for the effective clearing of artificial tubes, especially in-situ clearing of artificial tubes in a living being are covered in this disclosure. The devices and methods provide an elongated clearing member having a first end that is coupled to a driving mechanism and having a second working end that is subjected to repetitive motion for clearing blockages within the artificial tube. The elongated clearing member includes either a fixed or an adjustable element that selectively defines the portion of the elongated clearing member that is insertable within the artificial tube. The proximal end of the clearing member is releasably secured to the driving mechanism and the driving mechanisms may comprise a wide variety of repetitive motion drivers such as voice coil motors, piezoelectric actuators, pneumatic actuators, DC motors, etc. These devices/methods may comprise a free-standing console for hands-free operation or may comprise hand-held versions. The distal working end of the clearing member may comprise tips of differing functions, including an irrigation/aspiration feature. | 05-05-2011 |
20120209303 | MEDICAL TOOL WITH ELECTROMECHANICAL CONTROL AND FEEDBACK - A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators. The reciprocating actuator drives a penetrating member, such as a needle, through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, a feedback system monitors electromechanical properties of a control signal of the device and automatically modifies control based thereon, e.g., electrical power to the reciprocating actuator is automatically terminated. | 08-16-2012 |
20130018304 | DEVICES FOR CLEARING BLOCKAGES IN IN-SITU ARTIFICIAL LUMENS - A device for the in situ clearing of blockages in a tube includes a controller and a clearing member. The controller can have a housing and an actuator for generating repetitive motion. The clearing member can be releasably coupled to the controller and suitable for insertion in the tube. The tube can be at least partially disposed within a living being. The controller can be located external to the living being. The clearing member can have a first end releasably coupled to the actuator, at least one flexible section which permits axial displacement of the clearing member, and a second end suitable for repetitively engaging and disrupting the blockage. The flexible section permits the clearing member to repetitively engage and disrupt the blockage within one of a straight and a curved portion of the artificial tube. | 01-17-2013 |
20130018305 | DEVICES FOR CLEARING BLOCKAGES IN IN-SITU ARTIFICIAL LUMENS - A method for the in situ clearing of blockages in artificial tubes completely or partially disposed within a living being is described. The method includes coupling a first end of a releasably-securable flexible clearing member to a controller, inserting a second working end of the flexible clearing member into an opening in the artificial tube, energizing the controller such that said flexible clearing member experiences repetitive motion, and positioning the flexible clearing member such that the second working end of the flexible clearing member comes into repetitive contact with the blockage for clearing the blockage therein. The controller remains outside of the living being and the flexible clearing member clears the blockage when positioned within a straight portion or within a curved portion of the artificial tube. | 01-17-2013 |
20130018331 | DEVICES FOR CLEARING BLOCKAGES IN IN-SITU ARTIFICIAL LUMENS - A device for the breaking-apart of occlusions includes a stationary fitting, a hollow tube and a second fitting configured to reciprocate so as to cause the hollow tube to be compressed and expanded. The hollow tube is coupled on one side to the stationary fitting, and the stationary fitting provides access to a hollow portion of the hollow tube. | 01-17-2013 |
20130066200 | MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS - A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators, including piezoelectric, voice coil, solenoids, pneumatics or fluidics. The reciprocating actuator drives a penetrating member, such as a needle, through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, electrical power to the reciprocating actuator is automatically terminated. One exemplary method for detecting this passage is via a fluid-containing syringe that is coupled to a channel within the penetrating member. Once the penetrating member tip has passed through the living tissue, the fluid within the syringe no longer experiences any pressure and a plunger within the syringe displaces indicating passage of the penetrating member tip. This motion can provide direct tactile feedback to an operator of the medical device or can automatically open a switch providing electrical power to the medical device. Alternatively, a pressure transducer can also monitor the pressure within the penetrating member channel and automatically activate the switch to cut off the electrical power. | 03-14-2013 |
20130072856 | MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS - A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators, including piezoelectric, voice coil, solenoids, pneumatics or fluidics. The reciprocating actuator drives a penetrating member, such as a needle, through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, electrical power to the reciprocating actuator is automatically terminated. One exemplary method for detecting this passage is via a fluid-containing syringe that is coupled to a channel within the penetrating member. Once the penetrating member tip has passed through the living tissue, the fluid within the syringe no longer experiences any pressure and a plunger within the syringe displaces indicating passage of the penetrating member tip. This motion can provide direct tactile feedback to an operator of the medical device or can automatically open a switch providing electrical power to the medical device. Alternatively, a pressure transducer can also monitor the pressure within the penetrating member channel and automatically activate the switch to cut off the electrical power. | 03-21-2013 |
20130072857 | MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS - A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators, including piezoelectric, voice coil, solenoids, pneumatics or fluidics. The reciprocating actuator drives a penetrating member, such as a needle, through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, electrical power to the reciprocating actuator is automatically terminated. One exemplary method for detecting this passage is via a fluid-containing syringe that is coupled to a channel within the penetrating member. Once the penetrating member tip has passed through the living tissue, the fluid within the syringe no longer experiences any pressure and a plunger within the syringe displaces indicating passage of the penetrating member tip. This motion can provide direct tactile feedback to an operator of the medical device or can automatically open a switch providing electrical power to the medical device. Alternatively, a pressure transducer can also monitor the pressure within the penetrating member channel and automatically activate the switch to cut off the electrical power. | 03-21-2013 |
20140039419 | Devices for Clearing Blockages in In-Situ Artificial Lumens - Devices and methods for the effective clearing of artificial tubes, especially in-situ clearing of artificial tubes in a living being are covered in this disclosure. An elongated clearing member includes either a fixed or an adjustable element that selectively defines the portion of the elongated clearing member that is insertable within the artificial tube. The proximal end of the clearing member is releasably secured to the driving mechanism and the driving mechanisms may comprise a wide variety of repetitive motion drivers such as voice coil motors, piezoelectric actuators, pneumatic actuators, DC motors, etc. These devices/methods may comprise a free-standing console for hands-free operation or may comprise hand-held versions. The distal working end of the clearing member may comprise tips of differing functions, including an irrigation/aspiration feature. | 02-06-2014 |
20140039448 | Method for Clearing Blockages in In-Situ Artificial Lumens - Devices and methods for the effective clearing of artificial tubes, especially in-situ clearing of artificial tubes in a living being are covered in this disclosure. An elongated clearing member includes either a fixed or an adjustable element that selectively defines the portion of the elongated clearing member that is insertable within the artificial tube. The proximal end of the clearing member is releasably secured to the driving mechanism and the driving mechanisms may comprise a wide variety of repetitive motion drivers such as voice coil motors, piezoelectric actuators, pneumatic actuators, DC motors, etc. These devices/methods may comprise a free-standing console for hands-free operation or may comprise hand-held versions. The distal working end of the clearing member may comprise tips of differing functions, including an irrigation/aspiration feature. | 02-06-2014 |
20140102445 | Active System for In-Situ Clearing of Secretions and Occlusions in Tubes - A device for removing secretions from an artificial tube is provided. The device may include a clearing catheter and a driving mechanism that may apply repetitive motion to the clearing catheter. In another version of the device, the clearing catheter may dispense irrigation fluid and aspirate the irrigation fluid. The clearing catheter may have an irrigation and an aspiration lumen that may both reciprocate with the clearing catheter. In another version a compliant member into which irrigation fluid is located may be present. | 04-17-2014 |
20140188055 | Devices for Clearing Blockages in In-Situ Artificial Lumens - Devices and methods for the effective clearing of artificial tubes, especially in-situ clearing of artificial tubes in a living being is covered in this disclosure. An elongated clearing member includes either a fixed or an adjustable element that selectively defines the portion of the elongated clearing member that is insertable within the artificial tube. The proximal end of the clearing member is releasably secured to the driving mechanism and the driving mechanisms may comprise a wide variety of repetitive motion drivers such as voice coil motors, piezoelectric actuators, pneumatic actuators, DC motors, etc. These devices/methods may comprise a free-standing console for hands-free operation or may comprise hand-held versions. The distal working end of the clearing member may comprise tips of differing functions, including an irrigation/aspiration feature. | 07-03-2014 |
20140323855 | Medical Tool for Reduced Penetration Force with Feedback Means - A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators, including piezoelectric, voice coil, solenoids, pneumatics or fluidics. The reciprocating actuator drives a penetrating member through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, electrical power to the reciprocating actuator is automatically terminated. A fluid-containing syringe may be coupled to a channel within the penetrating member. Once the penetrating member tip has passed through the living tissue, the fluid within the syringe no longer experiences any pressure and a plunger within the syringe displaces indicating passage of the penetrating member tip. This motion can provide direct tactile feedback to an operator of the medical device or can automatically open a switch providing electrical power to the medical device. | 10-30-2014 |
20150216557 | Medical Tool for Reduced Penetration Force - A medical device is provided having reduced penetration. The device includes a body having a central hollow channel and a piezoelectric transducer received within and secured to the body. The piezoelectric transducer has a hollow portion concentric with the central hollow channel. A tubular member is associated with and in communication with the piezoelectric transducer. The piezoelectric transducer is adapted for vibrating at a frequency to produce an oscillating displacement of the tubular member against or within surrounding tissue. The tubular member may be a hypodermic needle, a trocar needle, or a catheterization needle. | 08-06-2015 |
Patent application number | Description | Published |
20090069712 | MEDICAL TOOL FOR REDUCED PENETRATION FORCE - A medical device is provided having reduced penetration force. The device includes a body having a central hollow channel and a piezoelectric transducer received within and secured to the body. The piezoelectric transducer has a hollow portion concentric with the central hollow channel. A tubular member is associated with and in communication with the piezoelectric transducer. The tubular member has at least one open end formed concentric with the central hollow channel and the hollow portion of the piezoelectric transducer, wherein the transducer is adapted for vibrating at a frequency to produce an oscillating displacement of the tubular member. | 03-12-2009 |
20090069830 | EYE SURGICAL TOOL - The present invention is directed to a surgical cutting device having a body, a piezoelectric actuator received within and secured to the body and a blade associated with and in communication with the actuator. The actuator is adapted for vibrating at a frequency to produce an oscillating displacement of the blade. A method of operating the surgical cutting device is also provided wherein the cutting device includes an actuator which is adapted for vibrating at a frequency to produce a sinusoidal displacement of the blade in the range of 250-500 μm. | 03-12-2009 |
20100004558 | MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS - A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators, including piezoelectric, voice coil, solenoids, pneumatics or fluidics. The reciprocating actuator drives a penetrating member, such as a needle, through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, electrical power to the reciprocating actuator is automatically terminated. One exemplary method for detecting this passage is via a fluid-containing syringe that is coupled to a channel within the penetrating member. Once the penetrating member tip has passed through the living tissue, the fluid within the syringe no longer experiences any pressure and a plunger within the syringe displaces indicating passage of the penetrating member tip. This motion can provide direct tactile feedback to an operator of the medical device or can automatically open a switch providing electrical power to the medical device. Alternatively, a pressure transducer can also monitor the pressure within the penetrating member channel and automatically activate the switch to cut off the electrical power. | 01-07-2010 |
20100292632 | Transdermal Micro-Patch - A transdermal micro-patch for use with living tissue is provided. The micro-patch includes a first membrane, a reservoir, a micro-pump, flextensional transducers, a microelectronics circuit, and an optional sensor. The first membrane is permeable to allow the passage of fluid in either a unidirectional or bidirectional fashion. The reservoir is a container-like element capable of storing a fluid removed from or communicated into the tissue. The micro-pump facilitates transport of the fluid between the reservoir and first membrane. The flextensional transducers generate ultrasonic waves which are separately communicated into the tissue to transport fluid between the first membrane and tissue. Ultrasonic waves could interact to enhance the performance of the micro-patch. The microelectronics circuit controls both flextensional transducers and the micro-pump. The sensor could be embedded within the micro-patch to monitor temperature, pressure, or flow rate so as to avoid damage or irritation to the tissue. | 11-18-2010 |
20120078164 | MEDICAL TOOL FOR REDUCED PENETRATION FORCE - A medical device is provided having reduced penetration force. The device includes a body having a central hollow channel and a piezoelectric transducer received within and secured to the body. The piezoelectric transducer has a hollow portion concentric with the central hollow channel. A tubular member is associated with and in communication with the piezoelectric transducer. The tubular member has at least one open end formed concentric with the central hollow channel and the hollow portion of the piezoelectric transducer, wherein the transducer is adapted for vibrating at a frequency to produce an oscillating displacement of the tubular member. | 03-29-2012 |
Patent application number | Description | Published |
20080241064 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN - Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Compounds, compositions and methods of treating patients with metastatic colorectal cancer or stomach or esophageal cancer and for imaging metastatic colorectal cancer or stomach or esophageal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as drugs, gene therapeutics and antisense compounds to metastatic colorectal cancer or stomach or esophageal cells are disclosed. Vaccines compositions and methods of for treating and preventing metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. | 10-02-2008 |
20090215089 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN - Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. | 08-27-2009 |
20100015167 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN - Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Compounds, compositions and methods of treating patients with metastatic colorectal cancer or stomach or esophageal cancer and for imaging metastatic colorectal cancer or stomach or esophageal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as drugs, gene therapeutics and antisense compounds to metastatic colorectal cancer or stomach or esophageal cells are disclosed. Vaccines compositions and methods of for treating and preventing metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. | 01-21-2010 |
20110086064 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN - Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. | 04-14-2011 |
20110104050 | Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin - Screening and diagnostic reagents, kits and methods for primary and/or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing primary and/or metastatic stomach or esophageal cancer are disclosed. | 05-05-2011 |
20110250228 | Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin - Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. | 10-13-2011 |
20120308583 | USE OF GCC LIGANDS - Proliferation of colorectal, gastric and esophageal cancer cells is inhibited by administering ST receptor ligand. The number of ST receptor molecules on the surface of a colorectal cell or metastasized colorectal cancer cell are increased by administering an ST receptor ligand such that ligand comes into contact with an ST receptor on the surface of the colorectal cell. Pharmaceutical compositions comprise sterile, pyrogen free ST receptor ligand and a pharmaceutically acceptable carrier or diluent. Metastasized colorectal cancer is treated or imaged by increasing the number of ST receptor molecules on the surface of a metastasized colorectal cancer cell and then administering a pharmaceutical composition containing components that target the ST receptor for delivery of a therapeutic agent or imaging agent. Methods of detecting metastasized colorectal cancer are disclosed. Methods of delivering active compounds to a colorectal cell in an individual are disclosed. | 12-06-2012 |
20120321552 | Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin - Screening and diagnostic reagents, kits and methods for primary and/or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing primary and/or metastatic stomach or esophageal cancer are disclosed. | 12-20-2012 |
20150104382 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN - Screening and diagnostic reagents, kits and methods for primary and or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing primary and/or metastatic stomach for esophageal cancer are disclosed. | 04-16-2015 |
Patent application number | Description | Published |
20090044084 | Combined DC restoration double detection and loops - A method of double detection in a perpendicular magnetic read channel is disclosed. The method generally includes the steps of (A) generating an intermediate signal by performing a first detection on an input signal of the perpendicular read channel, the first detection having a first error rate, (B) generating a statistics signal based on the intermediate signal, the statistics signal conveying noise statistics that depend on data in the input signal and (C) generating an output signal by performing a second detection on the input signal using the noise statistics to reduce a second error rate of the second detection compared with the first error rate, wherein the first detection is independent of the second detection. | 02-12-2009 |
20100177419 | AGC Loop with Weighted Zero Forcing and LMS Error Sources and Methods for Using Such - Various embodiments of the present invention provide systems and methods for gain control. For example, some embodiments of the present invention provide variable gain control circuits. Such circuits include a zero forcing loop generating a zero forcing feedback and a least mean square loop generating a least mean square feedback. An error quantization circuit generates a hybrid feedback based upon a threshold condition using the zero forcing feedback and the least mean square feedback. A variable gain amplifier is at least in part controlled by a derivative of the hybrid feedback. | 07-15-2010 |
20100287420 | Systems and Methods for Adaptive Equalization in Recording Channels - Various embodiments of the present invention provide systems and methods for performing adaptive equalization. For example, various embodiments of the present invention provide methods for adaptive equalization that include providing a data processing system with an equalizer circuit ( | 11-11-2010 |
20120063022 | Systems and Methods for Inter-track Interference Compensation - Various embodiments of the present invention provide systems and methods for data processing. As an example, a data processing circuit is discussed that includes: a data buffer, an inter-track interference response circuit, and an inter-track interference signal estimator circuit. The data buffer is operable to store a previous track data set. The inter-track interference response circuit is operable to estimate an inter-track interference response from the previous track data set based at least in part on the previous track data set and a current track data set. The inter-track interference signal estimator circuit is operable to calculate an inter-track interference from the previous track data set based at least in part on the previous track data set and the inter-track interference response from the previous track data set. | 03-15-2012 |
20120063023 | Systems and Methods for Block-wise Inter-track Interference Compensation - Various embodiments of the present invention provide systems and methods for data processing. As an example, a block-wise data processing circuit is discussed that includes: a data buffer, an inter-track interference response circuit, and an inter-track interference signal estimator circuit. The data buffer is operable to store a previous track data set corresponding to a block. The inter-track interference response circuit is operable to estimate an inter-track interference response from the previous track data set across the block based at least in part on the previous track data set and a current track data set. The inter-track interference signal estimator circuit is operable to calculate an inter-track interference from the previous track data set across the block based at least in part on the previous track data set and the inter-track interference response from the previous track data set. | 03-15-2012 |
20120063024 | Systems and Methods for Handling Sector Gaps in Inter-track Interference Compensation - Various embodiments of the present invention provide systems and methods for data processing. As an example, a data processing circuit is discussed that includes an inter-track interference determination circuit operable to calculate an inter-track interference from a previous track data set based at least in part on the previous track data set and a current track data set. The previous track data set includes a gap. A portion of the data in the previous track data set corresponds to a previous track on a storage medium, and the data in the previous track data set corresponding to the gap corresponds to a track preceding a previous track. | 03-15-2012 |
20130021689 | STORAGE MEDIA INTER-TRACK INTERFERENCE CANCELLATION - Described embodiments provide a method of cancelling inter-track interference (ITI) from one or more sectors read from a desired track of a storage medium. A read channel reads sectors in a desired track of the storage medium. A decoder of the read channel decodes the read sectors, and if the read sectors are incorrectly recovered from the storage medium, selected sectors of a first adjacent track and a second adjacent track are read. An ITI canceller of the read channel estimates ITI in the read sectors of the desired track corresponding to the selected sectors of each adjacent track and subtracts the estimated ITI of each adjacent track from the data for the sectors of the desired track, providing updated sector data. The ITI cancelled data is replayed to the decoder, which decodes the ITT cancelled data and provides the decoded ITI cancelled data as output of the read channel. | 01-24-2013 |
20130070362 | ENERGY-BASED INTER-TRACK INTERFERENCE CANCELLATION - Described embodiments cancel inter-track interference (ITI) from one or more sectors read from a desired track of a storage medium. A read channel reads one or more sectors in the desired track and generates one or more groups of sample values corresponding to each of the sectors. An ITI canceller estimates an ITI response and an ITI signal for each sample value corresponding to (i) a next adjacent track and (ii) a previous adjacent track. If the estimated ITI response of the previous adjacent track reaches a predetermined threshold, the ITI canceller subtracts the estimated ITI signal corresponding to the previous adjacent track from each associated sample value of the desired track. If the estimated ITI response of the next adjacent track reaches a predetermined threshold, the ITI canceller subtracts the estimated ITI signal corresponding to the next adjacent track from each associated sample value of the desired track. | 03-21-2013 |
20130223199 | STORAGE MEDIA INTER-TRACK INTERFERENCE CANCELLATION - Described embodiments provide a method of cancelling inter-track interference (ITI) from one or more sectors read from a desired track of a storage medium. A read channel reads sectors in a desired track of the storage medium. An iterative decoder of the read channel decodes the read sectors, and if the read sectors are incorrectly recovered from the storage medium, selected sectors of a first adjacent track are read. An ITI canceller of the read channel estimates ITI in the read sectors of the desired track corresponding to the selected sectors of the adjacent track and subtracts the estimated ITI of the adjacent track from the data for the sectors of the desired track, providing updated sector data. The ITI cancelled data is replayed to the iterative decoder, which decodes the ITI cancelled data and provides the decoded ITI cancelled data as output data of the read channel. | 08-29-2013 |
20130286498 | INTER-TRACK INTERFERENCE MITIGATION IN MAGNETIC RECORDING SYSTEMS USING AVERAGED VALUES - Hardware-based methods and apparatus are provided for inter-track interference mitigation in magnetic recording systems using averaged values. Inter-track interference (ITI) is mitigated in a magnetic recording system by obtaining ITI cancellation data; and providing the ITI cancellation data for ITI mitigation, wherein the ITI mitigation is performed in combination with an averaging procedure for one or more of ITI mitigation of averaged data and averaging of ITI mitigated data. The sector is optionally decoded using the ITI mitigated samples. Samples for one or more side track sectors can also be averaged. The averaged side track samples can be provided as ITI cancellation data for ITI mitigation. The averaging procedure optionally applies a scaling factor to each read value. | 10-31-2013 |
20140153126 | Systems and Methods for Old Data Inter-track Interference Compensation - Systems and methods for data processing, and more particularly to estimating or calculating interference between tracks on a storage medium. | 06-05-2014 |
20140233129 | NOISE PREDICTIVE FILTER ADAPTATION FOR INTER-TRACK INTERFERENCE CANCELLATION - Systems, methods, devices, circuits for data processing, and more particularly to systems and methods for adapting noise predictive filters for inter-track interference cancellation in a data processing system. | 08-21-2014 |
20140286385 | Systems and Methods for Multi-Dimensional Signal Equalization - Embodiments are related to systems and methods for data processing, and more particularly to systems and methods for equalizing a data signal. | 09-25-2014 |
20150015984 | Storage Media Inter-Track interference Cancellation - Described embodiments provide a method of cancelling inter-track interference (ITI) from one or more sectors read from a desired track of a storage medium. A read channel reads sectors in a desired track of the storage medium. A decoder of the read channel decodes the read sectors, and if the read sectors are incorrectly recovered from the storage medium, selected sectors of a first adjacent track and a second adjacent track are read. An ITI canceller of the read channel estimates ITI in the read sectors of the desired track corresponding to the selected sectors of each adjacent track and subtracts the estimated ITI of each adjacent track from the data for the sectors of the desired track, providing updated sector data. The ITI cancelled data is replayed to the decoder, Which decodes the ITT cancelled data and provides the decoded ITI cancelled data as output of the read channel. | 01-15-2015 |
20150199991 | Multiple Track Detection - An apparatus for reading data includes an array of analog inputs operable to receive analog signals retrieved from a magnetic storage medium, wherein the analog inputs correspond to multiple data tracks on the magnetic storage medium, and wherein the number of analog inputs in the array of analog inputs is greater than the number of data tracks being read, at least one joint equalizer operable to filter the analog inputs to yield an equalized output for each of the data tracks being read, and at least one data detector operable to apply a detection algorithm to the equalized output from the joint equalizer to yield detected values for each of the data tracks being read. | 07-16-2015 |
20150255101 | TRACK MISREGISTRATION SENSITIVE INITIALIZATION OF JOINT EQUALIZER - A method of mitigating an effect of track misregistration on read performance in a system comprising an array-reader includes determining an estimated off-track condition, selecting translation coefficients based on the estimated off-track condition, determining updated equalizer coefficients by applying the translation coefficients to native equalizer coefficients, and applying the updated equalizer coefficients to signals received from the array-reader to output a read signal. | 09-10-2015 |